Virus-like Particles and Spectral Flow Cytometry for Identification of Dengue Virus-Specific B Cells in Mice and Humans
Viruses · 30.12.2025 · 18 (1) · 58
DOI: 10.3390/v18010058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 30.12.2025. Verfasst von Katherine Segura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá 110231, Colombia. Hauptthemen laut MEDLINE: Flow Cytometry, Dengue Virus, B-Lymphocytes, Dengue. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sistema General de Regalías de Colombia, Universidad Surcolombiana, Sistema General de Regalías, Pontificia Universidad Javeriana.
Abstract (Originalsprache)
Severe dengue virus (DENV) infections are associated with circulating non-neutralizing antibodies generated during heterotypic infections. Although antibodies are key mediators of both protection and pathogenesis, the specific dynamics of B cells (Bc) and their antibody responses remain insufficiently characterized due to limited methods of identifying DENV-specific Bc (DENV-Bc) and the absence of animal models resembling the human disease. Here, we developed a spectral flow cytometry assay employing biotinylated virus-like particles (VLPs) to detect DENV-Bc in C57BL/6 mice and children hospitalized with dengue. DENV-1 and DENV-2 VLPs were biotinylated, and the efficiency of biotin incorporation was assessed with an HABA-avidin assay and ELISA. Serotype specificity and optimal binding conditions were confirmed using hybridomas 4G2 (pan-flavivirus) and 3H5-1 (DENV-2 specific). Fluorescent agglutimers were subsequently generated by coupling biotinylated VLPs to streptavidin–fluorochrome complexes. Splenocytes from intraperitoneally DENV-infected mice and peripheral blood mononuclear cells (PBMCs) from naturally infected pediatric patients were stained with these VLPs and Bc-lineage markers. Biotinylated VLPs bound specifically to hybridomas, and this binding was competitively inhibited by unlabeled VLPs. After secondary DENV challenge, VLPs identified DENV-specific class-switched plasmablasts in mice. Circulating DENV-specific plasmablasts were also detected in children, with agglutimers enabling the discrimination of serotype-specific and cross-reactive responses in primary and secondary infections. This VLP-based approach represents a scalable platform to investigate the protective and pathogenic roles of DENV-Bc in infection and vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá 110231, Colombia.
- División de Inmunología, Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva 410010, Huila, Colombia.
ORCID-Profile: Katherine Segura, Federico Perdomo-Celis, Carlos F Narváez
Förderung
- Sistema General de Regalías de Colombia
- Universidad Surcolombiana
- Sistema General de Regalías, Pontificia Universidad Javeriana
Zitieren
APA
Segura, K., Martel, F., Franco, M. A., Perdomo-Celis, F., & Narváez, C. F. (2025). Virus-like Particles and Spectral Flow Cytometry for Identification of Dengue Virus-Specific B Cells in Mice and Humans. Viruses, 18(1), 58. https://doi.org/10.3390/v18010058
Vancouver
Segura K, Martel F, Franco MA, Perdomo-Celis F, Narváez CF. Virus-like Particles and Spectral Flow Cytometry for Identification of Dengue Virus-Specific B Cells in Mice and Humans. Viruses. 2025;18(1):58. doi:10.3390/v18010058
BibTeX
@article{Segura2025,
author = {Segura, Katherine and Martel, Fabiola and Franco, Manuel A and Perdomo-Celis, Federico and Narváez, Carlos F},
title = {Virus-like Particles and Spectral Flow Cytometry for Identification of Dengue Virus-Specific B Cells in Mice and Humans},
journal = {Viruses},
year = {2025},
volume = {18},
number = {1},
pages = {58},
doi = {10.3390/v18010058}
}
EUVIMED